Ligand Pharmaceuticals reported $29.17M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Agenus AGEN:US $ 18.91M 39K
Amgen AMGN:US $ 1.33B 99M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Baxter International BAX:US $ 817M 27M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Clovis Oncology CLVS:US $ 32.59M 3.38M
Eli Lilly And LLY:US $ 1.63B 67.2M
Enanta Pharmaceuticals ENTA:US $ 12.93M 2.45M
Endo International Ordinary Shares ENDP:US 180.83M 45.18M
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 1.96B 726M
Glaxosmithkline GSK:US 1.96B 726M
Harsco HSC:US $ 67.94M 1.22M
Heron Therapeutics HRTX:US $ 32.12M 836K
Immunogen IMGN:US $ 23.79M 7.14M
Insmed INSM:US $ 59.97M 3.23M
Intrexon XON:US $ 12.67M 6.91M
Karyopharm Therapeutics KPTI:US $ 37.34M 1.43M
Lannett LCI:US $ 17.57M 1.22M
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Macrogenics MGNX:US $ 13.67M 2.58M
Merk MRK:US $ 2.42B 118M
Pacira Pharmaceuticals PCRX:US $ 65M 743K
Pfizer PFE:US $ 3.2B 506M
Rigel Pharmaceuticals RIGL:US $ 26.98M 420K
Sangamo Biosciences SGMO:US $ 15.09M 185K
Spectrum Pharmaceuticals SPPI:US $ 9.38M 485K
Teva Pharmaceutical Industries TEVA:US 849M 30M
Veracyte VCYT:US $ 39.96M 4.18M